Our study suggested that CAV1 and CAV2 possess higher expression levels in HNSCC than in normal tissues, and the increase in expression represented poorer prognosis in HNSCC patients with positive, thereby verifying the experiments. This evidence concerns the gene CAV1 and head and neck squamous cell carcinoma.